STENTYS May Solve One of The Biggest Problems In Acute Coronary Syndrome
Gonzague Issenmann, CEO and co-founder of STENTYS, spoke with OneMedRadio and shared his insights on the industry and how the company has become a success.
Gonzague Issenmann, CEO and co-founder of STENTYS, spoke with OneMedRadio and shared his insights on the industry and how the company has become a success.
For patients who have survived a heart attack, things get worse before they get better if they get better at all. Nearly 2 million people worldwide suffer from permanent heart damage due to lack of an appropriate therapy after a heart attack.
Copyright © 2024 | WordPress Theme by MH Themes